Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. [electronic resource]
Producer: 20061106Description: 4825-32 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Celecoxib
- Cyclooxygenase Inhibitors -- therapeutic use
- Deoxycytidine -- administration & dosage
- Docetaxel
- Female
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Pyrazoles -- therapeutic use
- Sulfonamides -- therapeutic use
- Survival Analysis
- Taxoids -- administration & dosage
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.